Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
- PMID: 22198732
- DOI: 10.1038/nchembio.761
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
Abstract
Until now, a lack of inhibitors with high potency and selectivity in vivo has hampered investigation of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. We describe the design of skepinone-L, which is, to our knowledge, the first ATP-competitive p38 MAPK inhibitor with excellent in vivo efficacy and selectivity. Therefore, skepinone-L is a valuable probe for chemical biology research, and it may foster the development of a unique class of kinase inhibitors.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- PubChem-Substance/131287876
- PubChem-Substance/131287877
- PubChem-Substance/131287878
- PubChem-Substance/131287879
- PubChem-Substance/131287880
- PubChem-Substance/131287881
- PubChem-Substance/131287882
- PubChem-Substance/131287883
- PubChem-Substance/131287884
- PubChem-Substance/131287885
- PubChem-Substance/131287886
- PubChem-Substance/131287887
- PubChem-Substance/131287888
LinkOut - more resources
Full Text Sources